Neonatal glycine encephalopathy diagnosed by genetic sequencing: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20252618Keywords:
Glycine, Encephalopathy, Genetic, Non-ketotic HyperglycinemiaAbstract
Non-ketotic hyperglycinemia (NKH), also known as Glycine encephalopathy, is a rare inborn error of metabolism (IEM) inherited in an autosomal recessive manner. Homozygous or compound heterozygous mutations in GLDC gene, a component of the mitochondrial glycine cleavage system that encodes the P protein, cause Glycine encephalopathy 1(GCE1). Whereas, mutation in the AMT gene, which codes for the T protein of the mitochondrial glycine cleavage pathway, results in glycine encephalopathy 2 (GCE2). In severe cases, symptoms can include lethargy, poor feeding, seizures, breathing difficulties and death. We report the case of a term neonate who presented with lethargy, poor feeding, hypotonia and seizures. Newborn metabolic screening was negative. Whole Exome Sequencing (WES) was done, which identified, a homozygous 1 base pair deletion in exon 7 of the GLDC gene, which is classified as likely pathogenic, for glycine encephalopathy. Baby was treated with sodium benzoate, dextromethorphan and supportive measures. A normal TMS does not exclude the possibility of glycine encephalopathy. The above case highlights the importance of genetic tests like WES in the diagnostic evaluation of suspected metabolic disorders. Early diagnostic confirmation through genetic studies is necessary for timely and accurate management, prognostication as well as for genetic counseling.
Metrics
References
Iqbal M, Prasad M, Mordekar SR. Nonketotic hyperglycinemia case series. J Pediatr Neurosci. 2015;10(4):355-8. DOI: https://doi.org/10.4103/1817-1745.174445
Krawiec C, Anastasopoulou C. Nonketotic Hyperglycinemia. In: StatPearls. Publishing. 2023.
Kure S, Takayanagi M, Narisawa K, Tada K, Leisti J. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. J Clin Invest. 1992;90(1):160–4. DOI: https://doi.org/10.1172/JCI115831
Boneh A, Korman SH, Sato K, Kanno J, Matsubara Y, Lerer I, et al. A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. J Hum Genet. 2005;50(5):230–4. DOI: https://doi.org/10.1007/s10038-005-0243-y
von Wendt L, Alanko H, Sorri M, Toivakka E, Saukkonen AL, Similä S. Clinical and neurophysiological findings in heterozygotes for nonketotic hyperglycinemia. Clin Genet. 1981;19(2):94–100. DOI: https://doi.org/10.1111/j.1399-0004.1981.tb00677.x
Curtis R. Coughlin, Michael A. Swanson, Kathryn Kronquist et al. The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT, Gen Med. 2017;19(1):104-11. DOI: https://doi.org/10.1038/gim.2016.74
Ning JJ, Li F, Li SQ. Clinical and genetic analysis of nonketotic hyperglycinemia: A case report. World J Clin Cases. 2022;10(22):7982-8. DOI: https://doi.org/10.12998/wjcc.v10.i22.7982
Arya S, MeltonK. Seizures, apnea, lethargy, and persistent hiccups in a full-term newborn. Neoreviews. 2019;20(5):295–7. DOI: https://doi.org/10.1542/neo.20-5-e295
Parviz S, Hooshyar D. Neonatal nonketotic hyperglycinemia: a severe case with prenatal indicators and comprehensive review of recognition and management. Clin Case Rep. 2012;13:70035. DOI: https://doi.org/10.1002/ccr3.70035
Das S, Pal S, Zamal A, Saha AK. A case of neonatal encephalopathy. Neoreviews. 2024;25(5):290-4. DOI: https://doi.org/10.1542/neo.25-5-e290
Van Hove JLK, Coughlin C II, Swanson M, Hennermann JB. Nonketotic Hyperglycinemia. In: GeneReviews®. University of Washington, Seattle, Seattle (WA). 1993.
Nowak M, Chuchra P, Paprocka J. Nonketotic Hyperglycinemia: Insight into Current Therapies. J Clin Med. 2022;11(11):3027. DOI: https://doi.org/10.3390/jcm11113027
Flusser H, Korman SH, Sato K, Matsubara Y, Galil A, Kure S. Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. Neurology. 2006;64(8):1426–30. DOI: https://doi.org/10.1212/01.WNL.0000158475.12907.D6
Yu TW, Chahrour MH, Coulter ME, Jiralerspong S, Okamura-Ikeda K, Ataman B, et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron. 2013;77(2):259–73. DOI: https://doi.org/10.1016/j.neuron.2012.11.002
Dinopoulos A, Kure S, Chuck G, Sato K, Gilbert DL, Matsubara Y, et al. Glycine decarboxylase mutations: a distinctive phenotype of nonketotic hyperglycinemia in adults. Neurology. 200;64(7):1255–7. DOI: https://doi.org/10.1212/01.WNL.0000156800.23776.40
Tada K, Hayasaka K. Non-ketotic hyperglycinaemia: clinical and biochemical aspects. Eur J Pediatr. 1987;146(3):221–7. DOI: https://doi.org/10.1007/BF00716464
Schutgens RB, Ket JL, Hayasaka K, Tada K. Non-ketotic hyperglycinaemia due to a deficiency of T-protein in the glycine cleavage system in liver and brain. J Inherit Metab Dis. 1986;9(2):208–14. DOI: https://doi.org/10.1007/BF01799462
Van Hove JL, Kishnani PS, Demaerel P, Kahler SG, Miller C, Jaeken J, et al. Acute hydrocephalus in nonketotic hyperglycinemia. Neurology. 2000;54(3):754–6. DOI: https://doi.org/10.1212/WNL.54.3.754
Ando T, Nyhan WL, Gerritsen T, Gong L, Heiner DC, Bray PF. Metabolism of glycine in the nonketotic form of hyperglycinemia. Pediatr Res. 1968;2(4):254–63. DOI: https://doi.org/10.1203/00006450-196807000-00004
Frazier DM, Summer GK, Chamberlin HR. Hyperglycinuria and hyperglycinemia in two siblings with mild developmental delays. Am J Dis Child. 1978;132(8):777–81. DOI: https://doi.org/10.1001/archpedi.1978.02120330049013
Flannery DB, Pellock J, Bousounis D, Hunt P, Nance C, Wolf B. Nonketotic hyperglycinemia in two retarded adults: a mild form of infantile nonketotic hyperglycinemia. Neurology. 1983;33(8):1064–6. DOI: https://doi.org/10.1212/WNL.33.8.1064
Tan ES, Wiley V, Carpenter K, Wilcken B. Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening. Mol Genet Metab. 2007;90(4):446–8. DOI: https://doi.org/10.1016/j.ymgme.2006.11.010
Hamosh A, McDonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr. 1992;121(1):131–5. DOI: https://doi.org/10.1016/S0022-3476(05)82559-4
Zammarchi E, Donati MA, Ciani F, Pasquini E, Pela I, Fiorini P. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia. Neuropediatrics. 1994;25(5):274–6. DOI: https://doi.org/10.1055/s-2008-1073037
Downloads
Published
How to Cite
Issue
Section
